海外の治験の状況「脳卒中」での検索結果
120件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- RELY-ABLE long term multi-center extension of dabigatran treatment in patients with atrial fibrillation who completed the RE-LY trial and a cluster randomised trial to assess the effect of a knowledge translation intervention on patient outcomes - RELY-ABLE
- This is a study of the long term safety of dabigatran (intended indication: stroke prevention in patients with atrial fibrillation).Eligible patients received dabigatran during the RE-LY trial 1160.26.At the time of entry into RE-LY, patients had at least one risk factor for stroke (1) congestive heart failure, 2) left ventricular dysfunction, 3) age >75, 4) age >65 years with hypertension, diabetes or coronary artery disease or 5) previous stroke, systemic embolism or transient ischemic attack) MedDRA version: 9.1 Level: LLT Classification code 10003658 Term: Atrial fibrillation
- Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Netherlands, Poland, Portugal, Sweden, United Kingdom
- 2008-09-25
Authorised
- REVACEPT, AN INHIBITOR OF PLATELET ADHESION IN SYMPTOMATIC CAROTID STENOSIS: A PHASE II, MULTICENTRE; RANDOMISED, DOSE-FINDING, DOUBLE-BLIND AND PLACEBO-CONTROLLED SUPERIORITY STUDY WITH PARALLEL GROUPS
- Patients suffering from symptomatic carotid artery stenosis, transient ischemic attacks, amaurosis fugax or stroke and who presenting with microembolic signals. MedDRA version: 20.0 Level: PT Classification code 10007687 Term: Carotid artery stenosis System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Germany, United Kingdom
- 2011-11-28
Authorised
- The effect of dipyridamole on the pharmacokinetics of metformin.
- The antihyperglycemic drug metformin and the thrombocyte aggregation inhibitor dipyridamole are often used concomitantly in patients with diabetes who have suffered a transient ischemic attack or stroke. Gastrointestinal absorption of metformin is mediated by the equilibrative nucleoside transporter 4 (hENT4). Dipyridamole has been reported to inhibit hENT4 transport in vitro. Dipyridamole may therefore negatively influence the uptake of metformin from the gastrointestinal tract. MedDRA version: 14.1 Level: PT Classification code 10068071 Term: Inhibitory drug interaction System Organ Class: 10018065 - General disorders and administration site conditions MedDRA version: 14.1 Level: PT Classification code 10013710 Term: Drug interaction System Organ Class: 10018065 - General disorders and administration site conditions ;Therapeutic area: Body processes [G] - Chemical Phenomena [G02]
- Netherlands
- 2012-02-22
Authorised
- Chemical Safety/Tolerability of HF0220 and its Effect on Biochemical Markers Relevant to Patients with a Diagnosis of Mild to Moderate Alzheimer's Disease.
- HF0220 experimentally appears to exert its potential beneficial effects within the CNS and possibly other tissues by attenuating the adverse effects of oxidative stress. It is believed that this mechanism has the potential to reduce disease progression in a wide range of disorders of the nervous system, e.g. Alzheimer's and Parkinson's disease, and brain damage due to acute stroke and head injury. It may also apply to the protection of peripheral tissues, such as the heart and/or kidney. MedDRA version: 9.1 Level: HLT Classification code 10001897 Term: Alzheimer's disease (incl subtypes)
- Sweden, United Kingdom
- 2006-02-17
Authorised
- A Phase 2a Study of AMG 301 in Migraine Prevention
- Migraine br>MedDRA version: 20.0 Level: PT Classification code 10058734 Term: Migraine prophylaxis System Organ Class: 10042613 - Surgical and medical procedures ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Austria, Canada, Czech Republic, Denmark, Finland, Germany, Netherlands, Sweden, United States
- 2017-06-30
Authorised
- A Study of the Effects of AMG 334 to Prevent Migraine Headaches
- Prevention of episodic migraine br>MedDRA version: 20.0 Level: LLT Classification code 10027608 Term: Migraine, unspecified System Organ Class: 100000013920 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Canada, Denmark, Finland, Germany, Norway, Sweden, United States
- 2013-04-29
Authorised
- A study to see if galcanezumab is effective for migraine prevention in people who have not responded to or have not tolerated previous migraine prevention treatments
- Treatment-resistant Migraine br>MedDRA version: 20.0 Level: LLT Classification code 10027602 Term: Migraine headache System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Belgium, Canada, Czech Republic, Denmark, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Netherlands, Spain, United Kingdom, United States
- 2018-05-21
Authorised
- A study to see if galcanezumab is effective for migraine prevention in people who have not responded to or have not tolerated previous migraine prevention treatments
- Treatment-resistant Migraine br>MedDRA version: 20.0 Level: LLT Classification code 10027602 Term: Migraine headache System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Belgium, Canada, Czech Republic, Denmark, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Netherlands, Spain, United Kingdom, United States
- 2018-04-30
Authorised
- A study to evaluate the effects of AMG334 compared to placebo medication in the prophylactic treatment of migraine in adult patients who have already tried other prophylactic migraine treatments unsuccessfully
- Migraine Prevention MedDRA version: 20.0 Level: PT Classification code 10027599 Term: Migraine System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
- 2016-07-29
Authorised
- Botox block of the sphenopalatine ganglion in treatment of chronic migraine
- Chronic migraine br>MedDRA version: 17.0 Level: LLT Classification code 10066636 Term: Chronic migraine System Organ Class: 100000004852 ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
- Norway
- 2014-06-12
